CORRELATION BETWEEN ESTRADIOL SERUM LEVELS WITH XEROSTOMIA INVENTORY SCORE ON MENOPAUSAL WOMEN
Keywords:Menopause, Xerostomia, Estradiol
Objective: Menopause is a condition of permanent cessation of menstruation for 12 consecutive months. This occurs due to the loss of follicular ovarian activity so that estrogen levels decrease in the body. Menopause can occur at various ages, where the average age of menopause is 51-55 y. Menopause can affect oral tissues as well as other organ systems and cause xerostomia. Some of the symptoms of xerostomia include burning feelings, taste abnormalities, dysarthria, dysphagia, dysgeusia, and halitosis.
Methods: This study uses a case series design to assess the correlation between estradiol levels and the incidence of xerostomia in menopausal women. The incidence of xerostomia using the Xerostomia Inventory (XI) Score. This research was conducted in several places, namely H. Adam Malik General Hospital Medan and the hospital network of the Department of Obstetrics and Gynecology, Faculty of Medicine, University of Sumatra Utara. The study population was all postmenopausal women at the H. Adam Malik General Hospital in Medan and the Obgyn FK USU network hospital that met the study inclusion-exclusion criteria. This research was conducted in February with a minimum sample of 38 people.
Results: In this study, 38 samples were obtained. Based on the results of the study, it was found that the most age groups were in the range of 56-60 y, the duration of menopause in the 5-10 y group, and the highest Body Mass Index (BMI) was obesity. The mean value of estradiol in menopausal women was 23.61±8.37 pg/ml; the mean value of XI score in menopausal women was 24.29±9.44. The correlation of estradiol levels and XI scores in menopausal women is a strong negative correlation that is-0.651 (p value<0.05). Correlation value of XI score and obesity in menopausal women is a low positive correlation with r = 0.342 (p value<0.05) while the value of correlation XI score with menopausal women who are not obese is a strong positive correlation with r = 0.793 (p value<0, 05).
Conclusion: Changes in the oral cavity are caused by aging and hypoestrogenism. The mean age of postmenopausal women was 56.98±4.35, with a mean BMI of 28.24±4.41. Estradiol levels in menopausal women are lower than women of reproductive age in each phase of the menstrual cycle. Significant reduction in estrogen production during menopause causes a decrease in salivary flow, leading to hyposalivation and symptoms of xerostomia.
2. Iswayuni N. Pemberian ekstrak plasenta meningkatkan estradiol dan FSH serta mengurangi gejala menopause. Universitas Udayanan Denpasar; 2011.
3. Lubis JM. Korelasi kadar 25-hydroxyvitamin d dan kadar estradiol serum dengan densitas tulang pada wanita menopause. Universitas Sumatera Utara; 2015.
4. Baziad A. Menopause dan andropause. Yayasan Bina Pustaka Sarwono Prawirohardjo 2003.
5. Abementhy K, Hillard A, McFall P, Holloway D, Robinson J. Menopause: lifestyle and therapeutic approaches. Royal College of Nursing; 2015.
6. Nagpal NK. Water quality guidelines for pharmaceutically-active compounds (PhACs): 17?-ethinylestradiol (EE2). Ministry of Environment Province of British Columbia; 2009. p. 1-27.
7. Rasgon NL. The effects if estrogen on brain function. Baltimore: The Johns Hopkins University Press; 2006. p. 9–45.
8. Wilson MMG. Menopause. Clin Geriatr Med 2003;19:483–506.
9. The practice committee of the American society for reproductive medicine (ASRM). The menopausal transition. Fertil Steril 2004;82(Suppl 1):107.
10. Chen C, Gong X, Shang X. The roles of estrogen and estrogen receptors in gastrointestinal disease. Oncol Lett 2019;18:5673-80.
11. Porcheri C, Mitsiadis TA. Physiology, pathology and regeneration of salivary glands. Cells 2019;8:976.
12. Minicucci EM, Pires RBC, Vieira RA. Assessing the impact of menopause on salivary flow and xerostomia. Australian Dental J 2013;58:230–4.
13. Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manage 2015;11:45–51.
14. AL-Kholy EA, Mahmoud MA, Nomany FA. The relationship between salivary levels of cortisol, chromogranin A (CgA) and xerostomia in post-menopausal women. Elsevier. Tanta Dental J 2014;11:161e168.
15. Thomson WM, Putten GJ, Baat CB. Shoertening the xerostomia inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:322–7.
16. Niklander S, Veas L, Barrera C. Risk factors, hyposalivation and impact of xerostomia on oral helath-related quality of life. Original Res Community Dental Health 2017;31:e14.
17. Kaur K, Kaur P, Singh B, Singh K, Kaur K, Narang RS. Gustatory functional level and oral dryness: impact of menopause on women health. J Adv Med Dent Sci Res 2018;6:25-9.
18. Raviraj J, Sunil V, Charitha M. Influence of menopause on oral health: a cross-sectional study. Int J Health Sci Res 2016;6:232-5.
19. Rivera Gomez B, Hernandez Vallejo G, Arriba-de la Fuente L, Lopez Cantor M, Diaz M, Lopez Pintor RM. The relationship between the levels of salivary cortisol and the presence of xerostomia in menopausal women. A preliminary study. Med Oral Patol Oral Cir Bucal 2006;11:E407-12.
20. Kaur N, Malla VG, Gupta S. Serum estradiol level and postmenopausal symptoms in surgical and natural menopause. Int J Reprod Contracept Obstet Gynecol 2017;6:3920-3.
21. Gholizadeh S, Sadatmahalleh SJ, Ziaei S. The association between estradiol levels and cognitive function in postmenopausal women. Int J Reprod BioMed 2018;16:455-8.
22. Gao WL, Wu LS, Zi JH, Wu B, Li YZ, Song YC, et al. Measurement of serum estrogen and estrogen metabolites in pre-and postmenopausal women with osteoarthritis using high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. Brazilian J Med Biol Res 2015;48:146-53.
23. Jones ME, Schoemaker M, Rae M, Folkerd EJ, Dowsett M, Ashworth, et al. Changes in estradiol and testosterone levels in postmenopausal women after changes in body mass index. J Clin Endocrinol Metab 2013;98:2967–74.
24. Puspita E, Siregar M, Adenin I. Correlation of estradiol serum levels with classification of osteoporosis risk OSTA (Osteoporosis self-assessment tools for Asian) in menopause women. Bali Med J 2017;6:52-5.
25. Agha Hosseini F, Mirzaii Dizgah I. Unstimulated whole saliva parathyroid hormone in postmenopausal women with xerostomia. J Contemp Dent Pract 2011;12:196-9.
26. Suri V, Suri V. Menopause and oral health. J Midlife Health 2014;5:115-20.
27. Singh B, Sheikh S, Pallagatti S, Kaur K, Sohi R. Evaluation of salivary calcium and salivary parathyroid levels in postmenopausal women with and without oral dryness. Contemp Clin Dent 2013;4:488-92.
28. Hosseini FA, Dizgah IM. Unstimulated saliva 17?-estradiol and xerostomia in menopause. Gynecol Endocrinol 2012;28:199-202.
29. Tremblay M, Brisson D, Gaudet D. Association between salivary pH and metabolic syndrome in women: a cross-sectional study. BMC Oral Health 2012;12:40.
30. Fajrin FN, Agus Z, Kasuma N. Hubungan body mass index dengan laju aliran saliva (Studi pada Mahasiswa Fakultas Kedokteran Gigi Universitas Andalas). Maj Ked Gi Ind 2015;1:156–62.